IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery
Can Intraoperative systemic lidocaine decrease postoperative opioid consumption and improve
 quality of recovery after laparoscopic gastric bypass surgery? The hypotheses:does the use of
 intraoperative systemic lidocaine decrease postoperative opioid consumption and improve
 quality of recovery after laparoscopic gastric bypass surgery.

 This study has the potential to confirm an opioid sparing strategy for morbid obese patients
 undergoing laparoscopic gastric bypass surgery. The high incidence of obstructive sleep apnea
 and the increased risk of postoperative hypoxemia make the development of opioid sparing
 techniques in this patient population warranted.
Inclusion Criteria:

 -  ASA I, II,III;

 -  BMI > 35 kg/m2,

 -  Age between 18-70,

 -  Fluent in English,

 -  Patients undergoing laparoscopic gastric bypass,

 -  EKG within 3 months.

 Exclusion Criteria:

 -  History of allergy to local anesthetics,

 -  History of chronic opioid use,

 -  Pregnant patients,

 -  History of EKG abnormalities.

 Dropout: Conversion to open, patient or surgeon request.